Idexx Laboratories IDXX
NASDAQ IDXX
$518.00 +4.86 (+0.95%)
At close: Oct 9, 2026 · 4:00 PM EDT

Idexx Laboratories (IDXX) Net Equity Issued and Repurchased (2009 - 2026)

Updated

Idexx Laboratories' Net Equity Issued and Repurchased was $32.91 million in Q2 2026, up 89.9% from $17.33 million a year earlier and up 81.2% from the prior quarter.

Analysis

Idexx Laboratories (IDXX) Net Equity Issued and Repurchased (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Idexx Laboratories' Net Equity Issued and Repurchased was $119.91 million through Jun 30, 2026, up 180.3% year-over-year; for FY2025, it was $93.36 million, up 109.8% from FY2024.

  • Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 12.7% (FY2020 to FY2025).
  • In earlier years, Net Equity Issued and Repurchased was $44.49 million in FY2024 (-5.4%), $47.03 million in FY2023 (+31.6%), $35.75 million in FY2022 (-23.2%) and $46.57 million in FY2021 (-9.3%).
  • Quarterly Net Equity Issued and Repurchased has moved between $4.88 million (Q3 2022) and $50.97 million (Q3 2025) over five years.
  • Compared with a year earlier, Net Equity Issued and Repurchased has increased for five straight quarters, with growth averaging 164.0% over the last eight quarters.
  • The best year-over-year quarter for Net Equity Issued and Repurchased over five years was Q3 2025 (growth of 920.2%); the worst was Q1 2025 (a decline of 65.5%).
  • Per Business Quant data, IDXX's Net Equity Issued and Repurchased in the three quarters before Q2 2026 was $18.16 million (Q1 2026), $17.87 million (Q4 2025) and $50.97 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn 138.00 Mn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn -9.00 Mn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn 1.20 Bn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn 6.00 Mn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn -
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn -346.00 Mn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn -
10 Idexx Laboratories 40.86 Bn 40.07 Bn 779.09 Mn -313.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -313.89 Mn
Mar 31, 2026 -332.88 Mn
Dec 31, 2025 -219.91 Mn
Sep 30, 2025 -189.23 Mn
Jun 30, 2025 -320.78 Mn
Mar 31, 2025 -393.70 Mn
Dec 31, 2024 -232.74 Mn
Sep 30, 2024 -215.76 Mn
Jun 30, 2024 -210.16 Mn
Mar 31, 2024 -133.89 Mn
Dec 31, 2023 -25.52 Mn
Sep 30, 2023 -22.45 Mn
Jun 30, 2023 10.29 Mn
Mar 31, 2023 12.80 Mn
Dec 31, 2022 -61.53 Mn
Sep 30, 2022 -167.75 Mn
Jun 30, 2022 -300.04 Mn
Mar 31, 2022 -254.64 Mn
Dec 31, 2021 -235.62 Mn
Sep 30, 2021 -171.18 Mn
API Access

Idexx Laboratories Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=IDXX&period=max&api_key=YOUR_API_KEY